LINCOLN Stock Overview
Engages in manufacturing and trading of pharmaceutical products in India and internationally.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for LINCOLN from our risk checks.
Lincoln Pharmaceuticals Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹566.00 |
52 Week High | ₹755.15 |
52 Week Low | ₹371.00 |
Beta | 0.68 |
1 Month Change | -6.38% |
3 Month Change | -16.83% |
1 Year Change | 49.28% |
3 Year Change | 95.78% |
5 Year Change | 231.77% |
Change since IPO | 158.86% |
Recent News & Updates
Recent updates
Lincoln Pharmaceuticals Limited's (NSE:LINCOLN) Business And Shares Still Trailing The Market
Mar 14Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Nov 04Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 14Lincoln Pharmaceuticals (NSE:LINCOLN) Is Paying Out A Dividend Of ₹1.50
Aug 31Lincoln Pharmaceuticals' (NSE:LINCOLN) Dividend Will Be ₹1.50
Sep 12Lincoln Pharmaceuticals (NSE:LINCOLN) Is Due To Pay A Dividend Of ₹1.50
Aug 29If You Like EPS Growth Then Check Out Lincoln Pharmaceuticals (NSE:LINCOLN) Before It's Too Late
Feb 14Should You Be Adding Lincoln Pharmaceuticals (NSE:LINCOLN) To Your Watchlist Today?
Aug 16Here's Why I Think Lincoln Pharmaceuticals (NSE:LINCOLN) Is An Interesting Stock
May 06Is Lincoln Pharmaceuticals Limited (NSE:LINCOLN) A Smart Choice For Dividend Investors?
Apr 03Does Lincoln Pharmaceuticals (NSE:LINCOLN) Have A Healthy Balance Sheet?
Mar 15Could The Market Be Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Given Its Attractive Financial Prospects?
Feb 28Insider Buying: The Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Whole Time Director Just Bought 15% More Shares
Feb 12Does Lincoln Pharmaceuticals (NSE:LINCOLN) Deserve A Spot On Your Watchlist?
Feb 01Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 27% Gain In The Last Five Years
Jan 19Trade Alert: The Whole Time Director Of Lincoln Pharmaceuticals Limited (NSE:LINCOLN), Munjal Patel, Has Just Spent ₹20m Buying 9.2% More Shares
Jan 06Why Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Is A Dividend Rockstar
Dec 27Lincoln Pharmaceuticals's (NSE:LINCOLN) Earnings Are Growing But Is There More To The Story?
Dec 14Have Insiders Been Buying Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Shares This Year?
Dec 01Declining Stock and Solid Fundamentals: Is The Market Wrong About Lincoln Pharmaceuticals Limited (NSE:LINCOLN)?
Nov 18Is Lincoln Pharmaceuticals (NSE:LINCOLN) A Risky Investment?
Nov 05Is Now The Time To Put Lincoln Pharmaceuticals (NSE:LINCOLN) On Your Watchlist?
Oct 23Lincoln Pharmaceuticals (NSE:LINCOLN) Shareholders Booked A 74% Gain In The Last Year
Oct 05Lincoln Pharmaceuticals Limited (NSE:LINCOLN) Vies For A Place In Your Dividend Portfolio: Here's Why
Sep 18Shareholder Returns
LINCOLN | IN Pharmaceuticals | IN Market | |
---|---|---|---|
7D | -0.2% | -1.9% | -2.4% |
1Y | 49.3% | 54.1% | 41.0% |
Return vs Industry: LINCOLN underperformed the Indian Pharmaceuticals industry which returned 54.1% over the past year.
Return vs Market: LINCOLN exceeded the Indian Market which returned 41% over the past year.
Price Volatility
LINCOLN volatility | |
---|---|
LINCOLN Average Weekly Movement | 4.4% |
Pharmaceuticals Industry Average Movement | 5.9% |
Market Average Movement | 6.4% |
10% most volatile stocks in IN Market | 9.4% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: LINCOLN's share price has been volatile over the past 3 months.
Volatility Over Time: LINCOLN's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1979 | 1,645 | Mahendrabhai Patel | www.lincolnpharma.com |
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India and internationally. The company provides products in the areas of cough and cold, anti-allergic, and anti-asthmatics; sterile ophthalmic eye drops and ointment; anti-malarial; vitamins, minerals, and antioxidants; anti-bacterial, anti-viral, and anti-fungal vitamins; analgesic and anti-pyretic; anti-psychotic, anti-convulsant, anti-depressant, and anti-diabetic; cardiac anti-hypertensives, and diuretic; and anti-diarrheal, anti-spasmodic, and laxative, as well as dermatologist preparations, gynecological products, gastrointestinal rang, otology products, and phosphodiesterase type 5 inhibitor and general anesthetics. It also offers branded generics.
Lincoln Pharmaceuticals Limited Fundamentals Summary
LINCOLN fundamental statistics | |
---|---|
Market cap | ₹11.25b |
Earnings (TTM) | ₹933.05m |
Revenue (TTM) | ₹6.15b |
12.1x
P/E Ratio1.8x
P/S RatioIs LINCOLN overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LINCOLN income statement (TTM) | |
---|---|
Revenue | ₹6.15b |
Cost of Revenue | ₹2.78b |
Gross Profit | ₹3.37b |
Other Expenses | ₹2.43b |
Earnings | ₹933.05m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 46.58 |
Gross Margin | 54.74% |
Net Profit Margin | 15.17% |
Debt/Equity Ratio | 0.2% |
How did LINCOLN perform over the long term?
See historical performance and comparison